GlassScriptPhysician profile
Asif M Lakha
NPI 1710143193
$2,340.80
in general payments reported to CMS, 2019-2025
6 companies · $1,485 in 2025
The $1,485 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.07 · 2020: $166 · 2021: $68.00 · 2023: $219 · 2024: $379 · 2025: $1,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $875 · Travel and Lodging: $768 · Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $875.00 |
| Travel and Lodging | $767.73 |
| Food and Beverage | $440.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,093.09 | 2019-2025 | General - Therapies, Axios, Spyglass |
| Olympus Medical Systems Corporation | $875.00 | 2025 | Evis Exera III Duodenovideoscope |
| Ambu INC. | $153.23 | 2020 | |
| Apollo Endosurgery US INC | $136.25 | 2023 | Overstitch Endoscopic Suturing System |
| Janssen Scientific Affairs, LLC | $57.01 | 2023 | Stelara |
| Conmed Corporation | $26.22 | 2023 | Conmed Biliary |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asif Lakha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.